Analyst Profile

Followed by 613 followers
.
Puneet Souda

Puneet Souda

SVB Securities
Wall Street Analyst
#7,951 out of 8,160 Wall Street Analysts
#23,750 out of 24,427 experts

Success Rate

41%
152 out of 375 transactions made a profit

Average Return

-9.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Puneet Souda's trades since 2014 and holding each position for 1 Year would result in 40.53% of your transactions generating a profit, with an average return of -9.3% per rating.

Stock Rating Distribution

537Ratings
84.36% Buy
15.64% Hold
0.00% Sell
Distribution of Puneet Souda's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
CryoPort Inc
(CYRX)
Rating:Buy
Date:Nov 08, 2019 - Nov 08, 2020
Return:+225.20%
The most profitable rating made by Puneet Souda

Puneet Souda's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Baxter International
Oct 20, 2014
Buy
Reiterated
$80.00
(50.32% Upside)
1Ratings
0%
-4.70%
PTHN
Patheon NV
Jun 09, 2017
Hold
Downgraded
1Ratings
0.00%
T2 Biosystems
Aug 24, 2021
Buy
Reiterated
$3.00
(77.51% Upside)
9Ratings
0%
-69.50%
HTG Molecular Diagnostics
Aug 24, 2021
Buy
Reiterated
$10.00
(3014.29% Upside)
7Ratings
0%
-71.47%
Galecto
Apr 29, 2022
Buy
Reiterated
$16.00
(959.60% Upside)
1Ratings
0%
-6.50%
Centogene NV
Jul 15, 2022
Buy
Reiterated
$6.00
(654.81% Upside)
10Ratings
0%
-76.02%
Abcam
Sep 12, 2022
Buy
Reiterated
$25.00
(47.06% Upside)
10Ratings
38%
-6.81%
Thermo Fisher
Oct 31, 2022
Buy
Reiterated
27Ratings
81%
+12.06%
Hologic
Oct 31, 2022
Buy
Reiterated
$78.00
(1.96% Upside)
8Ratings
86%
+5.94%
Repligen
Nov 01, 2022
Buy
Reiterated
$230.00
(23.62% Upside)
19Ratings
25%
-0.11%
List of latest recommendations made by Puneet Souda. Click to expand and see Puneet Souda's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >